Cook Meredith 4

What Happened Meredith Cook, Sr. VP, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares in an open-market transaction on June 12, 2026. The shares were sold at $82.03 per share for a total transaction value of $41,015. This was a sale (not a purchase) and is typically viewed as routine insider selling rather than a direct bullish signal.

Key Details

• Transaction date: 2026-06-12
• Transaction type/code: Open-market sale (S)
• Price per share: $82.03
• Shares sold: 500
• Total proceeds: $41,015
• Shares owned after transaction: Not specified in the provided filing
• Footnote: Sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025
• Filing date: 2026-06-15 — filed within the SEC’s Form 4 reporting window (timely)

Context Sales executed under a pre-established Rule 10b5-1 plan are pre-scheduled and often reflect planned liquidity or diversification rather than new information about the company. For retail investors, purchases by insiders tend to carry more weight as potential positive signals; routine sales alone should not be over-interpreted without broader insider activity or company developments.